Caplin Point Laboratories Share Price Live
Live Caplin Point Laboratories Share Price Chart
Caplin Point Laboratories Performance
Days Range
| Previous Close | ₹1,918.80 |
|---|---|
| Open | ₹1,915 |
| Volume | 59,702 |
| Day's Range | ₹1,879.20 - ₹1,939.80 |
|---|---|
| 52W Range | ₹1,599.00 - ₹2,641.00 |
| Market Cap | ₹14,576.38 Cr |
Caplin Point Laboratories Fundamentals
| ROCE(TTM) | 23.29 |
|---|---|
| P/E Ratio (TTM) | 24.44 |
| P/B Ratio | 4.61 |
| Industry P/E | 33.01 |
| Debt to Equity | 0 |
| ROE | 18.64 |
| EPS (TTM) | 77.46 |
| Dividend Yield | 0.31 |
| Book Value | 415.64 |
| Face Value | 2 |
| ROCE(TTM) | 23.29 |
|---|---|
| P/E Ratio (TTM) | 24.44 |
| P/B Ratio | 4.61 |
| Industry P/E | 33.01 |
| Debt to Equity | 0 |
| ROE | 18.64 |
|---|---|
| EPS (TTM) | 77.46 |
| Dividend Yield | 0.31 |
| Book Value | 415.64 |
| Face Value | 2 |
Caplin Point Laboratories Financials
| Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | |
|---|---|---|---|---|
| Net Sales | 492.96 | 502.45 | 510.22 | 534.04 |
| Expenses | 346.87 | 351.43 | 348.75 | 363.27 |
| Profit before tax | 177.26 | 176.67 | 184.46 | 201.00 |
| Operating Profit | 140.07 | 145.28 | 150.76 | 160.23 |
| Net Profit | 140.07 | 145.28 | 150.76 | 160.23 |
| ESP in Rs | 18.28 | 18.75 | 20.10 | 20.32 |
Caplin Point Laboratories Shareholding Pattern
| Held by | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|
| Promoters | 70.56% | 70.56% | 70.56% | 70.56% | 70.57% |
| Flls | 3.7% | 4.86% | 5.73% | 6.17% | 6.51% |
| Dlls | 1.84% | 2.11% | 2.01% | 2.22% | 2.1% |
| Public | 23.9% | 22.47% | 21.7% | 21.05% | 20.82% |
About Caplin Point Laboratories
Incorporated in Apr.'90, Caplin Point Laboratories was promoted by P C Partheeban, T Palanisamy, S Karunakaran, S Jayaraman and B A Ahmed. The company manufactures pharmaceutical formulations in the form of tablets, ointments and capsules, liquid orals and oral powders.
The company came out with a public issue in Nov.'94 and expanded its production capacity by setting up a new unit to manufacture its range of products, at Pondicherry. The company has retained its SSI status even after the expansion and thus will be out of the purview of the DPCO. During 1993-94, Triwin (a partnership firm) was merged with Caplin Point.
The company entered into a technical agreement with American Remedies, US, and Concord Laboratories, US, for specific products, with a 30% buyback arrangement. It also imports bio-technological products to market them in India.
The company has established a trading branch in Nairobi, Kenya, to sell its products in East Africa. It has also established a warehouse in Miami, US, by entering into a marketing tie-up with Lockett Medical Corporation, US.
Parent Organisation
Indian Private
Managing Director
C C Paarthipan
Founded
1990
NSE Symbol
CAPLIPOINT
Top Mutual Funds Invested in Caplin Point Lab Share
Top Mutual Funds Invested in Caplin Point Lab Share
| FUND NAME | AUM(%) |
|---|---|
| Samco Flexi Cap Fund | 6.32% |
| Samco ELSS Tax Saver Fund | 2.9% |
| UTI Healthcare Fund Direct Plan IDCW Payout | 2.22% |
| UTI Healthcare Fund Direct Plan IDCW Reinvestment | 2.22% |
| UTI Healthcare Fund | 2.22% |
Peer Comparison
Peer Comparison
| Stocks | LTP (₹) | Market Cap (cr) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | 1,779.9 0.20 (0.01%) | ₹4,27,033.64 | 1,548.0 - 1,910.0 |
| Divis Laboratories Ltd | 6,344.0 -29.00 (-0.46%) | ₹1,69,211.00 | 4,955.0 - 7,071.5 |
| Torrent Pharmaceuticals Ltd | 3,717.8 31.30 (0.85%) | ₹1,24,868.91 | 2,886.45 - 3,882.2 |
| Cipla Ltd | 1,502.3 -9.50 (-0.63%) | ₹1,22,082.50 | 1,335.0 - 1,673.0 |
| Dr Reddys Laboratories Ltd | 1,226.2 -17.70 (-1.42%) | ₹1,03,872.78 | 1,020.0 - 1,405.9 |
| Zydus Lifesciences Ltd | 923.2 -1.10 (-0.12%) | ₹93,026.33 | 795.0 - 1,059.05 |
Popular stocks
Caplin Point Lab Ltd FAQs
What is the share price of Caplin Point Lab Ltd (CAPLIPOINT) shares?
Caplin Point Lab Ltd (CAPLIPOINT) share price as of November 21, 2025, on NSE is Rs 1918.8 (NSE) and Rs 1918.8 (BSE) on BSE.
Can I buy Caplin Point Lab Ltd (CAPLIPOINT) from Angel One?
Yes, You can buy Caplin Point Lab Ltd (CAPLIPOINT) shares by opening a Demat account with Angel One.
How do I buy Caplin Point Lab Ltd (CAPLIPOINT) from Angel One?
Caplin Point Lab Ltd (CAPLIPOINT) share can be bought through the following modes:
1. Direct investment: You can buy Caplin Point Lab Ltd (CAPLIPOINT) shares by opening a Demat account with Angel One.
2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Caplin Point Lab Ltd (CAPLIPOINT) shares.
1. Direct investment: You can buy Caplin Point Lab Ltd (CAPLIPOINT) shares by opening a Demat account with Angel One.
2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Caplin Point Lab Ltd (CAPLIPOINT) shares.
What is the main business of Caplin Point Laboratories ?
Caplin Point is a pharmaceutical enterprise that was founded in 1990 which is a business of producing a variety of external applications such as ointments and creams.
Who are the promoters of Caplin Point Laboratories ?
P Vijayalakshmi, Paarthipan C C, Ashok Gorkey Partheeban, and Partheeban Vivek Siddarth are the major promoters of Caplin Point Laboratories.
What are the Subsidiaries that comes under Caplin Point Laboratories ?
Caplin Steriles, Argus Salud Pharma, Caplin Point Colombia S.A.S, Caplin Point Hong Kong, Caplin Onco and Caplin Point Pte Ltd are the Subsidiaries that come under Caplin Point Laboratories.
